beta-adrenoreceptor-cAMP-dependent inotropic interventions lose their
effectiveness depending on the degree of myocardial failure. This blun
ted effect of beta-adrenoreceptor-dependent stimulation might be due t
o a downregulation of beta-adrenoreceptors and an increase of inhibito
ry G-proteins leading to decreased intracellular cAMP-concentrations.
However, the maximal positive inotropic effect elicited by elevation o
f the extracellular [Ca2+] does not differ between failing and nonfail
ing human myocardium, indicating that terminally failing human myocard
ium is effective to increase force of contraction to the same degree a
s nonfailing tissue. Agents which increase force of contraction primar
ily via increasing the intracellular [Na+], e.g., cardiac glycosides a
nd the Na+-channel activator BDF 9148, exert a higher potency in faili
ng myocardium than in nonfailing tissue to increase force of contracti
on. This could result from an enhanced protein expression of the Na+/C
a2+ exchanger observed in diseased human hearts. Alterations in the in
tracellular Ca2+-homeostasis reported in failing myocardium lead to a
negative force-frequency-relationship and a prolonged relaxation. As t
he protein expression of SERCA IIa and phospholamban seems to be simil
iar in NYHA IV and nonfailing tissue, the reduced Ca2+-uptake may resu
lt from an altered regulation of these proteins, e.g., reduced phospho
rylation of phospholamban or the SERCA IIa. After inhibition of the Ca
2+-ATPase of the sarcoplasmic reticulum with the high specific inhibit
or cyclopiazonic acid the former positive force-frequency-relationship
became significantly less positive even in the nonfailing tissue and
twitch course became similiar to diseased hearts. These findings may b
e indicative for the importance of the Ca2+-reuptake mechanism into th
e sarcoplasmic reticulum in addition to the regulatory control at the
site of the contractile apparatus for the regulation of contraction an
d relaxation in human myocardium.